Sage-Biogen drug improves symptoms in postpartum depression study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street futures edge lower after AI selloff, telecom slide
- Brent crude hits more than five-month high on concern over Middle East escalation
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- UBS sees dip buyers stepping in to support gold at this level
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 253.84 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $253.84 | 52 Week High | $333.65 | |||
| Open | $253.84 | 52 Week Low | $223.02 | |||
| Day High | $253.84 | P/E | 32.50 | |||
| Day Low | $253.84 | EPS | $7.81 | |||
| Volume | 502 | |||||
| Sagebrush Gold Ltd. (NASDAQ: SAGE) | Delayed: 8.68 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.68 | 52 Week High | $62.64 | |||
| Open | $8.68 | 52 Week Low | $26.28 | |||
| Day High | $8.68 | P/E | N/A | |||
| Day Low | $8.68 | EPS | $-0.94 | |||
| Volume | 6 | |||||
